Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection.

Fuente: PubMed
Saved in:
Bibliographic Details
Main Authors: Conforti, Alessandro, Lavalle, Gabriella, Varini, Farbizio, Lucchetti, Linda, Cataldi, Giulia, Faticoni, Augusto, Ruggiero, Marco, Gentile, Martina, Gimignani, Giancarlo, Bassetti, Matteo
Format: Artículo científico
Language:en
Published: Journal of clinical medicine 2025
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266138856587265
author Conforti, Alessandro
Lavalle, Gabriella
Varini, Farbizio
Lucchetti, Linda
Cataldi, Giulia
Faticoni, Augusto
Ruggiero, Marco
Gentile, Martina
Gimignani, Giancarlo
Bassetti, Matteo
author_facet Conforti, Alessandro
Lavalle, Gabriella
Varini, Farbizio
Lucchetti, Linda
Cataldi, Giulia
Faticoni, Augusto
Ruggiero, Marco
Gentile, Martina
Gimignani, Giancarlo
Bassetti, Matteo
Conforti, Alessandro
Lavalle, Gabriella
Varini, Farbizio
Lucchetti, Linda
Cataldi, Giulia
Faticoni, Augusto
Ruggiero, Marco
Gentile, Martina
Gimignani, Giancarlo
Bassetti, Matteo
collection PubMed - marine biology
contents Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection. Conforti, Alessandro Lavalle, Gabriella Varini, Farbizio Lucchetti, Linda Cataldi, Giulia Faticoni, Augusto Ruggiero, Marco Gentile, Martina Gimignani, Giancarlo Bassetti, Matteo Infection with the Chikungunya virus (CHIKV) results in acute febrile diseases with severe polyarthritis, which can be followed by chronic rheumatic disease and long-term disability. To evaluate cytokine profiles in acute and chronic CHIKV infection and examine the relationship with clinical outcomes, including persistent musculoskeletal symptoms. Literature search was carried out systematically using electronic databases (PubMed, Embase, Scopus, and Google Scholar). Studies that met eligibility criteria were observational or intervention cohorts that measured levels of cytokines/chemokines in laboratory-confirmed CHIKV patients in acute (3 months) phases. Data was extracted on the study design, population, biomarkers, and clinical outcomes. As the assays were not homogeneous in terms of timing, outcome, and definitions, the findings were synthesized in narrative form using tabular representation. A total of 21 studies, including 4216 participants, were incorporated. In acute CHIKV, interleukin-6 (IL-6) (reported to be elevated in 81% of studies), IL-8 (77%), TNF-α (65%), and IFN-γ (60%) were most consistently increased, alongside interferon-inducible chemokines CXCL10/IP-10 and MCP-1. Chronic-phase cohorts showed persistent elevation of IL-6 (69%), IL-8 (63%), TNF-α (58%), and IL-17 (41%), especially among patients with prolonged arthralgia or arthritis. Chronic musculoskeletal symptoms were reported in 25-65% of cases, with some persisting beyond five years. A high degree of heterogeneity was observed in assay procedures and time of sampling. CHIKV infection is characterized by acute inflammatory surges and, in some cases, persistent cytokine dysregulation linked to chronic arthritis. These results showed the importance of prognostic biomarkers and targeted therapy.
format Artículo científico
id pubmed_41095803
institution PubMed
language en
publishDate 2025
publisher Journal of clinical medicine
record_format pubmed
spellingShingle Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection.
Conforti, Alessandro
Lavalle, Gabriella
Varini, Farbizio
Lucchetti, Linda
Cataldi, Giulia
Faticoni, Augusto
Ruggiero, Marco
Gentile, Martina
Gimignani, Giancarlo
Bassetti, Matteo
Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection. Conforti, Alessandro Lavalle, Gabriella Varini, Farbizio Lucchetti, Linda Cataldi, Giulia Faticoni, Augusto Ruggiero, Marco Gentile, Martina Gimignani, Giancarlo Bassetti, Matteo Infection with the Chikungunya virus (CHIKV) results in acute febrile diseases with severe polyarthritis, which can be followed by chronic rheumatic disease and long-term disability. To evaluate cytokine profiles in acute and chronic CHIKV infection and examine the relationship with clinical outcomes, including persistent musculoskeletal symptoms. Literature search was carried out systematically using electronic databases (PubMed, Embase, Scopus, and Google Scholar). Studies that met eligibility criteria were observational or intervention cohorts that measured levels of cytokines/chemokines in laboratory-confirmed CHIKV patients in acute (3 months) phases. Data was extracted on the study design, population, biomarkers, and clinical outcomes. As the assays were not homogeneous in terms of timing, outcome, and definitions, the findings were synthesized in narrative form using tabular representation. A total of 21 studies, including 4216 participants, were incorporated. In acute CHIKV, interleukin-6 (IL-6) (reported to be elevated in 81% of studies), IL-8 (77%), TNF-α (65%), and IFN-γ (60%) were most consistently increased, alongside interferon-inducible chemokines CXCL10/IP-10 and MCP-1. Chronic-phase cohorts showed persistent elevation of IL-6 (69%), IL-8 (63%), TNF-α (58%), and IL-17 (41%), especially among patients with prolonged arthralgia or arthritis. Chronic musculoskeletal symptoms were reported in 25-65% of cases, with some persisting beyond five years. A high degree of heterogeneity was observed in assay procedures and time of sampling. CHIKV infection is characterized by acute inflammatory surges and, in some cases, persistent cytokine dysregulation linked to chronic arthritis. These results showed the importance of prognostic biomarkers and targeted therapy.
title Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection.
url https://pubmed.ncbi.nlm.nih.gov/41095803/